Fragile X Syndrome

Treatment for Fragile X Syndrome Gets Fast Track Status

By March 15, 2018

A Phase 2 trial of OV101 in males with Fragile X syndrome aged 13 to 22 is planned for later in 2018. OV101 has previously been granted Orphan Drug status for Fragile X and Fast Track status for Angelman syndrome.